Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Dec 2023
A method for predicting which patients will benefit from radium-223, a common treatment for advanced prostate cancer that has spread to the bones, has been developed by researchers.
Read Full News(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)
Ethicist Art Caplan discusses a recent case involving attempted suicide and advance directives
Spinal anesthesia offers faster recovery, similar OR time, and significantly less opioid use, with no increase in cost or OR delays.
A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.
Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...
The U.S. health department has withdrawn an April charter renewal for a key vaccine advisory panel that laid out new membership rules and direction, citing an...
Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus outbreak linked to the Hondius cruise liner, the...
1.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
2.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
3.
The Kansas Cancer Center awarded two Indian American doctors professorships.
4.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer
5.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
1.
Case Study: Personalized Medicine Based on Genetic Profiling in Oncology
2.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
3.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
4.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
5.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge